NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER
Clinical trials for NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER explained in plain language.
Never miss a new study
Get alerted when new NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER trials appear
Sign up with your email to follow new studies for NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Softer chemo before transplant may help kids with blood disorders
Disease control Recruiting nowThis study is for people under 50 with non-cancerous blood or immune system diseases that can be treated with a donor stem cell transplant. Doctors want to see if a milder combination of chemotherapy drugs (treosulfan, fludarabine, and thiotepa) can safely prepare the body for ne…
Matched conditions: NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
New study investigates hidden blood cancer risks in ovarian cancer survivors
Knowledge-focused Recruiting nowThis study is for people who have had ovarian or other solid cancers. It aims to understand why some survivors later develop blood cancers. Researchers will look at genetic changes and treatment history to find risk factors. The goal is to improve monitoring and prevention for fu…
Matched conditions: NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:27 UTC